FCV vs PCV in Moderate to Severe ARDS
Flow Versus Pressure Controlled Ventilation in Patients With Moderate to Severe Acute Respiratory Distress Syndrome
1 other identifier
interventional
28
1 country
1
Brief Summary
The goal of this clinical trial is to compare flow-controlled ventilation (FCV) and pressure-controlled ventilation (PCV) in patients with moderate to severe acute respiratory distress syndrome on the intensive care unit. The main questions it aims to answer are:
- Is the mechanical power during flow-controlled ventilation lower than during pressure-controlled ventilation
- To gain more understanding about other physiological effects and potential benefits of flow-controlled ventilation in comparison to pressure-controlled ventilation (o.a. the end-expiratory lung volume and homogeneity of ventilation). Participants will be randomized between two ventilation mode sequences, being 90 minutes of FCV followed by 90 minutes of PCV or vice versa.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 7, 2023
CompletedStudy Start
First participant enrolled
September 12, 2023
CompletedFirst Posted
Study publicly available on registry
September 22, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2026
CompletedDecember 1, 2023
November 1, 2023
1.6 years
September 7, 2023
November 30, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mechanical power
Difference in mechanical power in J/min after 90 minutes of flow-controlled ventilation and 90 minutes of pressure-controlled ventilation
90 minutes
Secondary Outcomes (10)
End-expiratory lung volume
30 minutes
Dissipated energy
90 minutes
Airway pressures
30 and 90 minutes
Transpulmonary pressures
30 and 90 minutes
Minute volume
30 and 90 minutes
- +5 more secondary outcomes
Study Arms (2)
FCV-PCV
EXPERIMENTAL90 minutes of flow-controlled ventilation followed by 90 minutes of pressure-controlled ventilation.
PCV-FCV
EXPERIMENTAL90 minutes of pressure-controlled ventilation followed by 90 minutes of flow-controlled ventilation.
Interventions
Eligibility Criteria
You may qualify if:
- years or older
- Provided written informed consent
- Undergoing controlled mechanical ventilation via an endotracheal tube
- Meeting all criteria of the Berlin definition of ARDS
- Hypoxic respiratory failure within 1 week of a known clinical insult or new or worsening respiratory symptoms
- Bilateral opacities on X-ray or CT-scan not fully explained by effusions, lobar/lung collapse (atelectasis), or nodules
- Respiratory failure not fully explained by cardiac failure or fluid overload.
- Oxygenation: moderate ARDS P/F ratio between 101-200 mmHg, severe ARDS PF ratio ≤ 100mmHg, both with PEEP ≥ 5 cmH2O.
- Intubated ≤72 hours
You may not qualify if:
- Severe sputum stasis or production requiring frequent bronchial suctioning (more than 5 times per nurse shift)
- Untreated pneumothorax (i.e., no pleural drainage)
- Hemodynamic instability defined as a mean arterial pressure below 60mmHg not responding to fluids and/or vasopressors or a noradrenalin dose \>0.5mcrg/kg/min
- High (\>15 mmHg) or instable (an increase in sedation or osmotherapy is required) intracranial pressure
- An inner tube diameter of 6mm or less
- Intubated \> 72 hours
- Anticipating withdrawal of life support and/or shift to palliation as the goal of care
- Inability to perform adequate electrical impedance tomography (EIT) measurements with, e.g.:
- Have a thorax circumference inappropriate for EIT-belt
- Thoracic wounds, bandages or deformities preventing adequate fit of EIT-belt
- Recent (\<7 days) pulmonary surgery including pneumonectomy, lobectomy or lung transplantation
- ICD device present (potential interference with proper functioning of the EIT device and ICD device)
- Excessive subcutaneous emphysema
- Contra-indications for nasogastric tube or inability to perform adequate transpulmonary pressure measurements with, e.g.:
- Recent esophageal surgery
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Erasmus Medical Centerlead
- Maasstad Hospitalcollaborator
Study Sites (1)
Maasstad Hospital
Rotterdam, South Holland, 3079DZ, Netherlands
Related Publications (1)
van Oosten JP, Francovich JE, Weller D, Rietdijk W, Goedendorp N, Somhorst P, den Uil CA, Gommers D, Jonkman AH, Endeman H. Flow-controlled ventilation versus pressure-controlled ventilation in moderate to severe ARDS patients: a randomized crossover physiological study. Intensive Care Med Exp. 2025 Dec 24;13(1):137. doi: 10.1186/s40635-025-00847-4.
PMID: 41442110DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rik Endeman, Dr
Erasmus Medical Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 7, 2023
First Posted
September 22, 2023
Study Start
September 12, 2023
Primary Completion
May 1, 2025
Study Completion
May 1, 2026
Last Updated
December 1, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share